loading...

Short-form McGill Pain Questionnaire (SF-MPQ-2)

Melzack R; IMMPACT Group

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

The SF-MPQ was developed in 1984 and revised in 2009

Authors

Melzack R; IMMPACT Group

Copyright
SF-MPQ-2 © R. Melzack and the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), 2009. All Rights Reserved
Objective
To provide a comprehensive measure of pain symptoms of both neuropathic and non-neuropathic pain conditions
Therapeutic area
  • Nervous System Diseases
  • Pathological Conditions, Signs and Symptoms
  • Psychological Phenomena and Processes
  • Musculoskeletal and Neural Physiological Phenomena
Therapeutic indication

Pain

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Melzack R. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009;144:35-42 (PubMed Abstract)

Access the list of all bibliographic references (provided by the authors)


Contact and conditions of use

Authors

Melzack R; IMMPACT Group

Ronald Melzack, PhD

Department of Psychology
McGill University
Stewart Biological Sciences Bldg
Rm N8/5, 398-6084
1205 Dr Penfield Avenue
Montreal, PQ H3A 1B1
Canada
E-mail: ronald.melzack@mcgill.ca
Ronald Melzack Publications (PubMed) 

- IMMPACT Group (Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials) 

Robert H Dworkin, PhD
Professor of Anesthesiology, Neurology, Oncology, and Psychiatry
Director, Anesthesiology Clinical Research Center
University of Rochester School of Medicine and Dentistry
601 Elmwood Avenue, Box 604
Rochester, NY  14642
USA
Phone: +1 (585) 275-3524
Fax: +1 (585) 473-5007
E-mail:robert_dworkin@urmc.rochester.edu

Dworkin R Publications (PubMed)

Dennis C Turk, PhD
John and Emma Bonica Professor of Anesthesiology & Pain Research
Department of Anesthesiology
Box 356540
University of Washington
Seattle, Washington 98195
USA
Phone: +1 (206) 616-2626
Fax: +1 (206) 543-2958
E-mail:turkdc@u.washington.edu

Turk DC Publications (PubMed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students,  physicians, clinical practice, not-funded academic users:

If you do not receive specific funding for your study, you may download the questionnaire directly:

  1. Log in or Register for free
  2. Click the 'Online distribution' tab in the left menu bar and follow the instructions

Tutorials are available on our FAQs.

Funded academic users, healthcare organizations, commercial users & IT companies:

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner

Access fees

The Owner, the IMMPACT (Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials), as defined in section 1.02 may be subject to the laws of the United States including without limitation the United States Affordable Care Act of 2010 and specifically the Physician Payments Sunshine Act (the “US Sunshine Act”). Payments made directly to the Owner or through MRT may apply as Royalty Fees under the US Sunshine Act if the User is also subject to the laws as a medical device and drug manufacturers (“Applicable Manufacturers”) or group purchasing organizations (“GPOs”) that commercialize the medical device or drug in the USA.  The User acknowledges that the User may be required to report the Royalty Fees the appropriate party pursuant to the US Sunshine Act. Please consult www.CMS.govfor more information on the Sunshine Act or contact MRT.

Students, physicians, clinical practice, not-funded academic users:

No access fees are requested in this context.

Funded academic users, healthcare organizations, commercial users & IT companies:

Access fees may be requested depending on the user’s profile and on the study/project’s financing.
Please submit your request for a quote.

Conditions to translate

Please refer to the "Languages" tab

Conditions to implement in electronic applications

Exclusive licensor for e-versions of the questionnaireMapi Research Trust

  • The user shall follow the “Conditions of use”  mentioned above
  • In addition, in case the electronic version of the questionnaire is developed by a third party (IT Company, e-PRO vendor…), the user shall check with Mapi Research Trust that this third party has signed the necessary license agreement with Mapi Research Trust before developing the electronic version of the questionnaire.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

SF-MPQ-2

Afrikaans for South Africa*
Arabic for Israel*
Bulgarian for Bulgaria*
Croatian for Croatia
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
English for Australia*
English for Canada*
English for South Africa*
English for the UK*
Farsi for Iran
Finnish for Finland*
French for Belgium*
French for Canada*
French for Switzerland*
Georgian for Georgia*
German for Austria*
German for Germany*
German for Switzerland*
Hebrew for Israel*
Hindi for India*
Hungarian for Hungary*
Italian for Italy*
Italian for Switzerland*
Japanese for Japan*
Lithuanian for Lithuania
Malay for Malaysia
Moldavian for Moldavia*
Norwegian for Norway
Polish for Poland*
Romanian for Romania*
Russian for Moldavia*
Russian for Russia
Russian for Ukraine*
Serbian for Serbia*
Sinhalese for Sri Lanka
Spanish for Argentina*
Spanish for Colombia*
Spanish for Spain*
Spanish for the USA*
Swedish for Sweden*
Ukrainian for Ukraine*
* Performed by Mapi

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi

Online distribution

My study is not funded

  • I am a non-commercial user
  • I do not receive specific funding for my study
  • I intend to use the questionnaire in individual clinical practice or research study
Login SIGN up free

My study is funded

If your study is funded, or if you haven't found your translation in the Languages menu, please submit your request online.

Our team will get back to you as soon as possible.

E-versions

Tablet

Implemented electronically on TrialMax Slate® site-based devices

Member Access

Subscribe to PROQOLID to access to full informations

And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!

A question? Contact us